BRCA1/2 Mutation Testing in Patients with HER2-Negative Advanced Breast Cancer: Real-World Data from the United States, Europe, and Israel

SIMPLE SUMMARY: Poly(adenosine diphosphate-ribose) polymerase inhibitors have recently been shown to be effective for patients with human epidermal growth factor receptor 2—negative (HER2−) advanced breast cancer (ABC) who have a germline mutation in their breast cancer susceptibility gene 1 or 2 (B...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahtani, Reshma, Niyazov, Alexander, Arondekar, Bhakti, Lewis, Katie, Rider, Alex, Massey, Lucy, Lux, Michael Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656255/
https://www.ncbi.nlm.nih.gov/pubmed/36358816
http://dx.doi.org/10.3390/cancers14215399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656255/
https://www.ncbi.nlm.nih.gov/pubmed/36358816
http://dx.doi.org/10.3390/cancers14215399

Ejemplares similares